[This Article in
PDF print format]
Pharmacies in black neighborhoods
are much less likely to carry sufficient supplies of popular opioid painkillers
than those in white neighborhoods, a new study has found, leading researchers to
conclude that minorities are routinely undertreated for chronic pain.
The study found that the disparity between what is available to patients in
majority-black neighborhoods compared with majority-white areas had little to do
with income levels, as pharmacies in wealthy black neighborhoods were no more
likely to carry the prescription painkillers than those in poorer black
neighborhoods. In wealthy white neighborhoods, however, pharmacies were far more
likely to carry sufficient stock than in poor white communities.
"The pharmacies in minority areas generally say they stock limited amounts of
pain medication because the demand is not there," said Carmen R. Green, an
associate professor at the University of Michigan Medical School, who led the
"But the low-demand barrier does not ring true for me," she said. "We know that
minorities are more at risk of suffering chronic pain, and maybe they don't come
to local pharmacies because they've come to expect they won't carry the
medicines they need."
Green and other researchers said that the new study, published this week in the
Journal of Pain, is consistent with earlier studies showing that doctors were
less likely to prescribe opioid painkillers to minorities than to whites.
"I'm shocked by these results," said Ashish K. Jha, an expert in health care
disparities at the Harvard School of Public Health.
"There is no plausible explanation that makes sense," he said. "It's hard to
know what gets us there, but if pharmacies are stocking [narcotic painkillers]
at substantially lower levels for black people, what is clear is that there's no
good clinical reason for it."
The study found that one possible non-clinical explanation for the lower
availability is concern about illicit use, and the potential consequences for
The head of the Washington D.C. Pharmaceutical Association and one Capitol Hill
pharmacist agreed with that assessment. Association President Herbert Kwash said
many pharmacists in the District are reluctant to carry controlled drugs because
of concerns that they will be robbed and their customers endangered. For those
reasons, said pharmacist Michael Kim of Grubbs Pharmacy on East Capitol Street,
some druggists no longer carry prescription narcotics and have signs in their
front windows indicating that.
Pain diagnoses are notoriously difficult to make -- whether from an accident,
from chronic arthritis or back pain, or from cancer -- because there is no
objective way to measure suffering.
Research during the 1990s led many pain doctors to conclude that prescription
narcotics such as OxyContin, Dilaudid and Percocet could be used at higher
strength without a high risk of addiction. But the Drug Enforcement
Administration became increasingly concerned about the diversion of these
prescription narcotics, which agency officials argued became overprescribed and
That view led the DEA and local authorities to prosecute scores of doctors and
pharmacists for alleged improper and illegal prescribing, and a number are
serving lengthy jail terms. Two high-profile cases involved local practitioners
-- pain doctor William E. Hurwitz of McLean and pharmacist Emmanuel Thad Ereme,
who operated Hremt Pharmacy in District Heights. Both men said they were just
trying to help patients in pain, but juries concluded they were involved in
criminal conspiracies to distribute prescription narcotics.
Susan Winkler, vice president for policy for the American Pharmaceutical
Association, which represents pharmacists, said concern over DEA
"heavy-handedness" could play a role in the limited availability of controlled
pain drugs in some minority-neighborhood pharmacies.
Although the abuse of painkillers has reportedly been most widespread in rural
white areas, she said pharmacists everywhere have become increasingly concerned
about the risks of selling the controlled drugs. Patient demand determines which
drugs a pharmacy stocks, Winkler said, but the paperwork and DEA oversight
associated with the narcotic painkillers are also factors.
"For every violation, there is a substantial fine," she said. "And an
investigation of a pharmacist's practice, like for a physician, can send a real
chill throughout the health care practitioner community. . . . With the
controlled drugs, the pharmacist now has to determine whether a prescription is
legally valid and clinically appropriate, and that's a heavy burden."
Green's study, which surveyed 188 Michigan pharmacies, found stark differences
in how well drugstores were stocked with opioid painkillers. In Zip codes
predominantly inhabited by whites, 87 percent of pharmacies were deemed to have
sufficient supplies; 54 percent met that standard in predominantly minority Zip
The research also found a substantial difference between large chain stores and
independents. Although 91 percent of independents were found to be well supplied
with the painkillers, only 59 percent of chain stores met the criteria.
Valerie Stork, spokeswoman for the National Association of Chain Drug Stores,
said that although the DEA does track and monitor the sale of controlled drugs,
the agency does not directly mandate how much of a medication a pharmacy should
"It is up to each individual pharmacy to decide the quantity of controlled
substances to stock," she said.
[This Article in
PDF print format]